Term
X-Linked Agammaglobulinemia (Bruton's) |
|
Definition
Presentation Males Starts at 3-6 months (maternal IgG gone) Recurrent infections that don’t respond to antibiotics
Molecular Defect BTK Gene Defect prevents B cell maturation
Dx CD19+CD20+ mature B cells absent/reduced (Very low CD19+) Near absence of B cells & all antibody classes (immunoglobulins) (Very low CD19+) No germinal centers in lymphoid tissue
Tx Antibiotics, IVIG |
|
|
Term
Transient Hypogammaglobulinemia (of infancy) |
|
Definition
Presentation Both sexes Starts at 3-5 months, resolves by 2 years Recurrent pyogenic infections that don’t respond to antibiotics More common in premature infants
Molecular Defect B or TH cells
Dx Normal numbers of B cells (different than seen in XLA) IgG always low IgA low
Tx Antibiotics IVIG not usually given |
|
|
Term
|
Definition
Presentation Many asymptomatic Sinopulmonary infections Repeated infections by encapsulated bacteria May progress to common variable immunodeficiency (CVID)
Dx Low IgA (possible TH2 issue via IL-5)
Tx Antibiotics NO IVIG (possess IgE directed towards IgA ANAPHYLAXIS) |
|
|
Term
IgM & IgG Subclass Deficiencies |
|
Definition
Presentation Repeated infections by encapsulated bacteria (Streptococcus pneumonia) Often present with asthma Dx Decrease in either Measure by RIA
Tx Aggressive Antibiotics, don’t usually need IVIG |
|
|
Term
Common Variable Immunodeficiency (CVID) |
|
Definition
Presentation 1-5y, 15-20y May follow EBV infection Associated with IgA def. Pernicious Anemia Recurrent pyogenic bacterial infections Molecular Defects B-cell (CD19) No antibodies
Dx Normal numbers of B cells Absence of IgM & IgD; CD27 present IgG, IgA low
Tx Narrow-spectrum antibiotics (broad leads to infections by fungi) IVIG |
|
|
Term
|
Definition
Presentation Recurrent respiratory infections @ 1-2y More common in males Molecular Defects No class-switching from IgM to other types X-linked: CD40L on T cell males only Autosomal: CD40 & AID enzyme on B cell would be in females
Dx Reduced IgG (100%) Reduced IgA (>75%) Elevated IgM
Tx Antibiotics, IVIG New: BMT |
|
|
Term
X-Linked Lymphoproliferative Syndrome (Duncan Syndrome) |
|
Definition
Presentation Near fatal-EBV infection causing infectious mono Males only 3-5y @ dx B-cell lymphomas (Burkitt) Molecular Defect Gene that codes for SAP (signaling molecule in T, B, NK cells & eosinophils & platelets)
Dx Positive heterophile antibody test for infectious mono Atypical lymphocytes on blood smear +PCR for EBV DNA Liver damage in chem profile (AST, ALT)
Tx Antimicrobials Prophylactic IVIG Stem Cell transplant only cure, but success rate is low Rituximab (monoclonal antibody to CD20) |
|
|
Term
|
Definition
Presentation Susceptible to all types of infections Diarrhea, pneumonia
Tx Bone marrow transplant Subtypes |
|
|
Term
T-B+ (X-linked) (50% of all cases) T-B+ (autosomal) |
|
Definition
Molecular Defect y chain of receptor for IL-2, 4, 7, 9, & 15 No T or NK cells
Molecular defect Alpha-chain of IL-7 (No T or NK cells) JAK3 Tyrosine Kinase (No T cells |
|
|
Term
T-B- (Adenosine Deaminase Deficiency) |
|
Definition
No T or B cells present
Molecular Defect Adenosine Deaminase
Tx ADA enzyme supplement, BMT |
|
|
Term
|
Definition
Presentation Red, scaly skin resembling Graft-vs-Host rxn Massive skin & GI infiltration by eosinophils & TH2 cells Malnutrition (from protein loss) Loses weight after birth Hyper-IgE production No B Cells present
Molecular Defect “Leaky” RAG activity |
|
|
Term
T+B+ (Bare Lymphocyte Syndrome) |
|
Definition
Molecular Defect Lack MHC Class I, II, or both (HLA molecules absent) Class I (CD4+ TH cells) no collaboration between APCs & TH cells Class II (CD8+ Tc cells) TAP molecules to blame T-cell: zap-70 Sx: all types of infections live vaccine = lethal symptoms earlier than XLA, fatal before 1 y/o if untreated |
|
|
Term
Hereditary Ataxia-Telangiectasia |
|
Definition
Presentation 18 months Wobbly gait (Ataxia) Telangiectasia (dilated capillaries) on skin & eyes Severe sinus & lung infections
Molecular Defect DNA Repair Gene ATM (ataxia-telangiectasia mutated)
Dx Elevated alpha fetoprotein (AFP) & carcinoembryonic antigen (CEA) Low lymphocyte count Low IgA & IgE Absent adenoids, thymic shadow
Tx Antibiotics & IVIG |
|
|
Term
|
Definition
Presentation Males 20 months Bleeding disorders due to thrombocytopenia Recurrent bacterial infections Allergic rxns Petechiae, eczema, pneumonia Molecular Defect WASP (Wiskott-Aldrich Syndrome Protein)
Dx Very low platelets High IgE & IgA Low IgM & IgG
Tx Antimicrobials & IVIG Manage acute bleeding with platelet transfusions & packed RBCs Avoid food allergens |
|
|
Term
|
Definition
Presentation Recurrent “cold” staphylococcal abscesses (not inflamed) Eczematous dermatitis Skeletal features Fractures, coarse facial features, joint hyperextensibility, retained primary teeth NO bleeding disorder (unlike Wiskott-Aldrich) Molecular Defect STAT3 Protein (transcription factor essential for signaling from many IL, IFN, & CSF receptors) Overproduction of TH2 cytokines hyper-IgE (IL-4, IL-13) Underproduction of TH1-derived IFNy “cold” abscesses
Dx VERY high IgE (2 SD above) Eosinophilia w/ normal lymphocyte & PMN numbers
Tx: Antibiotics |
|
|
Term
DiGeorge Syndrome (Congenital Thymic Aplasia) |
|
Definition
Presentation No thymus or parathyroid glands Few or no T cells same infections as SCID Hypocalcemic Tetany (no PTH to stimulate Ca2+ production) Congenital heart & kidney problems Hypertelorism (increased eye distance), low-set ears, shortened philtrum of upper lip
Molecular Defect 22q11.2 deletion (not usually hereditary)
Dx T cells absent or diminished Low IgG Thymic shadow absent on X-ray
Tx Antibiotics BMT to restore immunologic function T-Cell function may be normal by age 5 w/o BMT ectopic thymic tissue |
|
|
Term
Chronic Mucocutaneous Candidiasis |
|
Definition
Presentation Oral thrush and/or skin infections (diaper rash) Can affect the nails
Molecular Defect No T-cells with TCRs that recognize candida antigens
Dx Identify Candida on skin scrapings
Tx Antifungal agents Transfer factor small proteins extracted from human donor lymphocytes sensitized to candida species specific cell immunity may be passively transferred by this approach |
|
|
Term
Autoimmune Lymphoproliferative Syndrome (ALPS) |
|
Definition
Presentation Thrombocytopenia petechia & bleeding Neutropenia recurrent infections Anemia fatigue Splenomegaly before age 3 Lymphadenopathy (swelling of lymph nodes) B-cell lymphoma night sweats, fever, pruritis (itiching), weight loss
Molecular Defect FAS (CD95) activates caspases to induce apoptosis
Dx Lymphadenopathy or splenomegaly lasting more than 6 months Elevated CD4-CD8- T cells (possible elevated CD3+??) Mutations in Fas gene Decreased RBC, Platelets, Neutrophils
Tx Antibiotics, IVIG Corticosteroids for anemia & thrombocytopenia Sargramostim for neutropenia |
|
|
Term
Chronic Granulomatous Disease (CGD) |
|
Definition
Presentation 2y, more common in males (x-linked & autosomal forms) Repeated infections by staph, serratia, aspergillus Granulomas Pneumonia Lymphadenitits Abscesses in skin, liver, & viscera Molecular Defect Phagocytes lack of functional NADPH oxidase X-linked: CYBB gene for gp91phox Autosomal: other subunits
Dx Nitroblue tetrazolium (NBT) reduction test CGD fails to reduce NBT to formazan No color change from yellow to purple
Tx Antimicrobials IFNy induces synthesis of opsonizing & complement activating cells (good for encapsulated bacteria) |
|
|
Term
Leukocyte Adhesion Deficiency 1 (LAD1) |
|
Definition
Presentation Impaired wound healing Soft tissue bacterial infections of mouth & GI tract Cannot form pus efficiently
Molecular Defect Defective CD18 common to LFA-1, CR3, CR4
Dx Leukocytosis Absence of CD18
Tx Antibiotics BMT or Stem Cell transplant |
|
|
Term
Leukocyte Adhesion Deficiency 2 (LAD2) |
|
Definition
Presentation Infections Growth & mental retardations
Molecular Defect Fucose metabolism Lack of CD15/Sialyl Lewis X
Dx Flow cytometry for CD15 Phagocyte migration & chemotaxis assays
Tx Antibiotics Fucose replacement therapy |
|
|
Term
|
Definition
Presentation Recurrent staph, strep, and pseudomonas infections of skin, lungs, respiratory tract Partial albinism of skin, hair, eyes Giant granules (lysosomes), defective melanosomes
Molecular Defect LYST Gene Defect (giant lysosomes)
Dx Giant granules in granulocytes apparent on stained blood smears Neutropenia Elevated Ig’s
Tx Antibiotics BMT |
|
|
Term
IL-12/IL-23/IFNy Deficiency |
|
Definition
Presentation Especially susceptible to weakly pathogenic mycobacteria Susceptible to other intracellular bacteria (salmonella enteriditis) Irregular skin lesions all over body
Molecular Defect IFNy receptor on macrophage STAT1 transcription factor IL-12 receptor on TH1 & NK cells |
|
|
Term
Hereditary Angioedema (HAE) |
|
Definition
Presentation Local edema of hands, face, arms, legs, genitals Laryngeal edema suffocation Stomach, GI abdominal pain, constipation, diarrhea
Molecular Defect Type 1 (85%): low levels of C1INH (C1 esterase inhibitor) Type 2: Normal/high levels of dysfunctional C1NH
Dx Low levels of C4
Tx Fresh frozen plasma before dental/surgical procedure Maintain airway, pain management |
|
|
Term
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Definition
Presentation Dark urine Budd-Chiari syndrome: severe abdominal pain Weakness, dyspnea, pallor, splenomegaly, Fe deficiency, severe headaches & eye pain, chronic infections
Molecular Defect GPI anchors of complement regulators Decay-accelerating factor (DAF) & CD59
Dx Assess DAF & CD59 Low RBC, WBC, & Platelets
Tx Prednisone/eculizumab for RBC lysis Stem cell transplant Treat anemia & thrombosis |
|
|
Term
Pernicious Anemia (Stomach) |
|
Definition
Presentation Beefy, red, smooth, sore tongue Weakness, dyspnea, anorexia, fever, diarrhea “Megaloblastic madness”: delusions, hallucinations Megaloblastic anemia May be associated with Helicobacter pylori infection
Onset: 30y+
Tx Vitamin B12
Organ Target Stomach Molecular Target Intrinsic factor Type II Hypersensitivity Rxn |
|
|
Term
|
Definition
Presentation Glomerulonephritis Pulmonary hemorrhage
Tx Acute Intubation, assisted ventilation, hemodialysis
Long-term Corticosteroids Cyclophosphamide (immunosuppression) Plasmapheresis
Target Organ Lungs, Kidney Molecular Target Complement fixing auto-antibodies (for Type IV collagen) Type II Hypersensitivity Rxn |
|
|
Term
Insulin-dependent Diabetes Mellitus |
|
Definition
Presentation
Onset: 11-12y, late 30s/40s Hyperglycemia & ketoacidosis Polyuria, polydpsia Polyphagia with weight loss Fatigue, weakness, muscle cramps Blurred vision
Tx Diet & exercise Insulin
Organ Target Pancreas Molecular Target Glutamic Acid Decarboxylase & alpha/beta cells HLA-DR3/DR4 Type IV Hypersensitivity |
|
|
Term
|
Definition
Presentation Muscle fatigue with exercise Progressive muscular weakness Chewing, swallowing, breathing Diplopia & ptosis (double vision & drooping eyelids) Women (common), 20-40y
Tx Cholinesterase inhibitors Corticosteroids IVIG
Organ Target Muscles Molecular Target ACh receptors in motor end plates of neuromuscular junctions Type II Hypersensitivity Rxn |
|
|
Term
|
Definition
Presentation Darkening of the skin Due to overproduction of corticotropin (stimulates melanocytes) Weight loss, diarrhea, vomiting, abdominal pain Muscle weakness, fatigue, low blood pressure Depression, irritability, loss of concentration
Tx Hormone replacement (cortisone)
Organ Target Adrenal glands Molecular Target ACTH Receptors Type II Hypersensitivity Rxn |
|
|
Term
Bullous Diseases – Pemphigus Vulgaris |
|
Definition
Presentation Erosion of skin & mucous membranes Painful, non-itchy blisters
Tx Prednisone, immunosuppressives, or plasmapheresis
Organ Target Skin and/or mucoa Molecular Target Desmogleins Type II Hypersensitivity Rxn |
|
|
Term
Bullous Diseases – Bullous Pemphigoid |
|
Definition
Presentation Subepidermal blistering RARELY involves mucous membranes Tense, itchy blisters Eotaxin in basal layer of epidermis recruits eosinophils
Onset: 65y
Tx Prednisone, immunosuppressives, tetracycline
Organ Target Skin and/or mucosa Molecular Target Hemidesmosomal antigens Type II Hypersensitivity Rxn |
|
|
Term
Graves Disease/Thyrotoxicosis |
|
Definition
Presentation Hyperthyroidism (Increased T3 & T4) Myxedema, Exophthalmos Sweating, smooth moist skin Frequent bowel movements, Diarrhea, Weight loss Goiter, Rapid heart rate, palpitations widened pulse pressure Tremor Women (common); 30s & 40s
Tx Anti-thyroid drugs, surgery
Organ Target Thyroid Molecular Target TSH Receptors Thyroperoxidase & thyroglobulin Type II Hypersensitivity Rxn |
|
|
Term
|
Definition
Presentation Goiter made of WBCs Dry skin, decreased sweating, cold intolerance Constipation, Weight gain Fatigue, memory deficits Hoarseness Joint pain, muscle cramps
Tx Thyroxine
Organ Target Thyroid Molecular Target TSH Receptors Thyroperoxidase & thyroglobulin |
|
|
Term
|
Definition
Presentation Morning stiffness, gets better in late day Arthritis of 3 or more joints SubQ rheumatoid nodules Serum Rheumatoid Factor (RF) Reactive with Fc fragment of IgG Females (common) Initial trigger; mycoplasma, EBV, parvovirus, rubella
Tx NSAIDs, Corticosteroids, COX-2 inhibitors, anti-TNFa agents
Organ Target Joints (fingers, wrists, elbows, shoulders, knees) Molecular Target HLA-DR4, TH1 & TH17 cells Type IV Hypersensitivity |
|
|
Term
Systemic Lupus Erythematosus (SLE) |
|
Definition
Presentation Arthritis, Glomerulonephritis, Erythema (AGE) Malar (butterfly) rash over nose & cheeks Fever, headache, pericarditis “Lumpy-bumpy” pattern on immunoflorescence Severe cases Hemolytic anemia Thrombocytopenic purpura Renal damage Hair loss Discoid rash & mouth sores 90% are women estrogen worsens disease African, Caribbean, Asian, & Hispanic descent more likely
Onset: 20-40y
Dx Anti-dsDNA antibodies very specific for SLE Correlates with renal damage
Tx Avoid sunlight to prevent flairs NSAIDS, steroids Methotrexate Type III Hypersensitivity |
|
|
Term
Sjogren Syndrome (Sicca Syndrome) |
|
Definition
Presentation Dry eyes, mouth, vaginal mucosa Sometimes dry nose, larynx, bronchi Usually associated with RA or SLE Salivary gland enlargement
Dx Anti-SS-A/Ro & anti-SS-B/La antibodies
Tx Symptomatic Type IV Hypersensitivity |
|
|
Term
Guillain-Barre Syndrome (GBS) |
|
Definition
Presentation Ascending paralysis affecting peripheral nerves Weakness & diminished reflexes Paresthesia, numbness, facial droop, double vision Commonly occurs after infectious disease or vaccination Campylobacter jejuni most common antecedent Inflammatory cellular response controlled by CD4+ TH cells Autoantibodies to nerves (myelin sheath)
Tx Keep airway clear, plasmapheresis IVIG Physical & Speech therapy Type IV Hypersensitivity |
|
|
Term
|
Definition
Presentation Chronic relapsing paralysis that affects CNS Most common neurologic disease of young adults Peak incidence at 35y (females more likely) Paresthesias (prickling, tingling) in extremities Weakness or clumsiness, Partial blindness, Bladder control issues, Vertigo & ataxia Emotional disturbances Due to demyelination of CNS tissue TH1 cells specific for myelin basic protein Tc, macrophages, & microglia attack oligodendrocytes Initiating inflammatory stimulus via viral infection
Dx MRI plaques of demyelination with perivascular inflammation primarily in white matter Oligoclonal IgG bands detected Elevated myelin basic protein (MBP)
Tx Corticosteroids ABC’s (avonex, betaserone, copaxone) Natalizumab Regular exercise & PT Type IV Hypersensitivity Rxn |
|
|
Term
|
Definition
Presentation: Early: Fever (IL-1), Cachexia (TNF@), night sweats and diarrhea Later: Significant loss of CD4+ T cells with decrease in humoral and cell mediated immune functions. CD4/CD8 is normally 2:1 but it reverses to 1:2 Kaposi's Sarcoma, P. Jerovi pneumonia, cryptosporidium (small bowel), cerebral toxoplasmosis, lymphomas by EBV, vericella zoster virus
Transmission: Sexual contact, transfer of blood, transfer by contaminated needles, mother-child during birth or breast feeding
HIV infects all cells that infect CD4 (TH, monocytes, Macrophages, Dendritic cells, microglial cells)
M tropic: CCR5 prefer binding to macrophages in early in disease. T-tropic viruses: CXCR4.
No vaccine or cure
TX: HAART (highly active retro antiviral therapy) |
|
|